1.Modern radiation therapy for extranodal lymphomas:field and dose guidelines from international lymphomaradiation oncology group
Yahalom JOACHIM ; Illidge TIM ; Specht LENA ; T.hoppe RICHARD ; Li YEXIONG ; Tsang RICHARD ; Wirth ANDREW ; Zhuanbo YANG ; Xin LIU ; Shunan QI ; Yexiong LI
Chinese Journal of Radiation Oncology 2017;26(9):971-984
Extranodal lymphomas (ENLs) comprise about a third of all non-Hodgkin lymphomas (NHL).Radiation therapy (RT) is frequently used as either primary therapy (particularly for indolent ENL),consolidation after systemic therapy,salvage treatment,or palliation.The wide range of presentations of ENL,involving any organ in the body and the spectrum of histological sub-types,poses a challenge both for routine clinical care and for the conduct of prospective and retrospective studies.This has led to uncertainty and lack of consistency in RT approaches between centers and clinicians.Thus far there is a lack of guidelines for the use of RT in the management of ENL.This report presents an effort by the International Lymphoma Radiation Oncology Group (ILROG) to harmonize and standardize the principles of treatment of ENL,and to address the technical challenges of simulation,volume definition and treatment planning for the most frequently involved organs.Specifically,detailed recommendations for RT volumes are provided.We have applied the same modern principles of involved site radiation therapy as previously developed and published as guidelines for Hodgkin lymphoma and nodal NHL.We have adopted RT volume definitions based on the International Commission on Radiation Units and Measurements (ICRU),as has been widely adopted by the field of radiation oncology for solid tumors.Organ-specific recommendations take into account histological subtype,anatomy,the treatment intent,and other treatment modalities that may be have been used before RT.
2.Modern radiation therapy for nodal non-Hodgkin lymphom-target definition and dose guidelines from the international lymphoma radiation oncology group
Lllidge Tim ; Specht Lena ; Yahalom Joachim ; Aleman Berthe ; Berthelsen Kiil Anne ; Constine Louis ; Dabaja Bouthaina ; Dharmarajan Kavita ; Ng Andrea ; Ricardi Umberto ; Wirth Andrew ; Jianxiong Cui ; Yong Yang ; Shunang Qi
Chinese Journal of Radiation Oncology 2017;26(8):845-852
The guidelines represent an agreed consensus view of the ILROG steering committee on the use of RT in NHL in the modern era. The roles of reduced volume and reduced doses are addressed,integrating modern imaging with 3-dimensional planning and advanced techniques of RT delivery. In the modern era,combined-modality treatment with systemic therapy is appropriate. A new concept,involved-site RT,defines the clinical target volume. For indolent NHL,often treated with RT alone,larger fields should be considered. Newer treatment techniques,including intensity modulated RT,breath holding,image guided RT,and 4-dimensional imaging,should be implemented,and their use is expected to decrease significantly the risk for normal tissue damage while still achieving the primary goal of local tumor control.